In 2023, the United States was the leading importer of glycosides, valued at $192.31 Million, demonstrating a slight growth over the previous year. Italy and China followed, with import values of $113.18 Million and $95.41 Million, respectively. The five-year CAGR reveals a moderate increase, highlighting consistent demand. France, Malaysia, Mexico, Japan, India, Germany, and Russia rounded out the list, collectively showing stable trends. Notably, India and Malaysia had the most significant growth percentage over the two-year analysis period, reflecting expanding markets.
Looking ahead, key trends to observe include potential shifts in market demand driven by innovations in pharmaceuticals and food industries utilizing glycosides, alongside changes in trade policies that could impact importing dynamics. Environmental sustainability and synthetic alternatives could also influence future demand. Monitoring these factors will be crucial for assessing the evolving landscape of glycoside imports.
Top countries in Top Importers of Glycosides
| # | 10 Countries | Million US Dollars | Last Year | |
|---|---|---|---|---|
| 1 | 1 United States | 192.31 | 2016 | |
| 2 | 2 Italy | 113.18 | 2016 | |
| 3 | 3 China | 95.41 | 2016 | |
| 4 | 4 France | 70.41 | 2016 | |
| 5 | 5 Malaysia | 67.51 | 2016 | |
| 6 | 6 Mexico | 59.73 | 2016 | |
| 7 | 7 Japan | 54.23 | 2016 | |
| 8 | 8 India | 51.99 | 2016 | |
| 9 | 9 Germany | 50.93 | 2016 | |
| 10 | 10 Russia | 43.43 | 2016 |
